“I find great value in attending NUCON each year. The interactive sessions provide an opportunity to speak directly with product experts and developers. The road map of what is to come was great to see and was a highlight.”, said Raymond Waller, Director, Ascension Brighton Center for Recovery.

CINCINNATI (PRWEB)
October 22, 2019

iPatientCare, a pioneer in cloud-based ambulatory EHR and Revenue Cycle Management services, successfully concluded its annual national user conference in Cincinnati on 19th October 2019. With this conference, iPatientCare also kicked-off its 10th anniversary celebrations of this annual user conference which was first organized in 2010.

This year’s event focused on ‘Evolving healthcare landscape’ and featured two keynote speakers, Dr. Yousuf Ahmad, President, and Chief Executive Officer, AssureCare LLC, and Raymond Waller, Director, Ascension Brighton Center for Recovery. During this two-day event, iPatientCare channel partners, certified professionals, business partners, end-users and healthcare experts from iPatientCare gathered together to reflect on their evolution in the healthcare field, to celebrate accomplishments, to welcome new practitioners to their networks, and to investigate what new directions the next ten years may bring.

Udayan Mandavia, Chief Growth Officer, iPatientCare/AssureCare, presented the Sneak peek of R20 and discussed the evolution of iPatientCare technologies, new phases and developments of iPatientCare products and how they will be launching new innovative projects in the future. He said, “Starting from developing a mobile computing system for the US Army to ramping up with ambulatory EHR today, iPatientCare has been successful in addressing the evolving healthcare needs. Beyond EHR and PMS, iPatientCare now looks forward to working for the hospital’s side, with a focus on managing population health as a whole.”

Besides these informative sessions, a dedicated exhibition area featuring iPatientCare partners and NUCON 2019 sponsors such as Amazon Web Services (AWS), Practice Insight, CoverMyMeds, ConnectiveRX, Upland Interfax and Scriptel Corporation offered participants the opportunity to browse through demos, offerings, and their unique solutions.

I find great value in attending NUCON each year. The interactive sessions provide an opportunity to speak directly with product experts and developers. The road map of what is to come was great to see and was a highlight. I can’t wait to see what iPatientCare puts together for the next year’s conference!”, said Raymond Waller, Director, Ascension Brighton Center for Recovery.

About iPatientCare

iPatientCare is a full suite of innovative healthcare products and value-added services that help physician offices, rural health clinics, and community/federally qualified health centers (CHC/FQHC) nationwide in improving the health of their patients, enhancing patient care through care management/coordination/analytics, and reducing costs of care delivery.

The awards-winning EHR, integrated practice solutions and value-added services, such as, the revenue cycle enhancement and quality improvement consulting, provide everything you need to control your practice operations, increase revenues, and provide better patient care.

iPatientCare helps healthcare providers to dramatically reduce A/R days and improve collections rates, reduce billing costs, eliminate the burden of repeatable, high volume work on their internal teams, and plug gaps in staffing and internal bandwidth. The revenue cycle teams are comprised of senior executives with extensive experience in clinically-driven revenue cycle management systems including certified billers and coders with managerial capabilities to facilitate client interactions, escalations and SLA.

The iPatientCare EHR – version 18.0, has received 2015 Edition ONC Health IT certification by Drummond Group, an Office of the National Coordinator-Authorized Certification Body (ONC-ACB), in accordance with the applicable eligible professional certification criteria adopted by the Secretary of Health and Human Services (HHS). Full certification details can be found at the ONC Certified Health IT Product List.

As part of its MACRA-ready solutions, iPatientCare has been recognized as a qualified MACRA-MIPS registry by CMS, and has a distinguished credit of being selected as a preferred EHR and medical billing software by more than 70,000 users nationwide, numerous hospitals/health systems, federally funded regional extension centers, and in the past by the US Army and NASA Space Medicine.

Visit https://www.iPatientCare.com for more information.

Share article on social media or email:

Xtalks Life Science Webinars

When a company is growing, business leaders responsible for various departments like R&D, marketing, quality, regulatory, manufacturing and IT start to see the symptoms of growing organization and pain points in bringing new products to market faster.

TORONTO (PRWEB)
October 22, 2019

On Tuesday, November 5, 2019 at 9am EST (2pm GMT/UK), join Prabhu Salimath, Senior Management Consultant, Life Sciences at TECHNIA and Daniel Lennwald, Sales Executive, Medical Devices at TECHNIA in a live webinar where they will discuss how to start and execute the process of selecting the right PLM solution for your business. They will also cover what to consider when evaluating different platforms and vendors.

When a company is growing, business leaders responsible for various departments like R&D, marketing, quality, regulatory, manufacturing and IT start to see the symptoms of growing organization and pain points in bringing new products to market faster. This is even more challenging for a life sciences company due to regulatory and compliance-driven environment.

In such a situation, business leaders realize that a transformation is needed in business processes and systems in the area of product innovation, product development and product data management. This change not only needs a new system or business platform that can enable cross-functional people collaboration, but also a relook at current processes and way of working. Transformation requires a streamlined and harmonized process across the product lifecycle that can help and support respective department users to keep up with company goals. Product Lifecycle Management (PLM) is often defined as a combination of those streamlined processes and Product Innovation Platform (PIP).

After recognizing that such a transformation is needed, the next step is to realize it. In a multi-disciplinary product company with cross functional teams and global organization, it is not always a straight forward path towards a truly global and long-term PLM solution. In this free webinar, featured speakers will provide an overview of what steps need to be taken to make it happen. They will also discuss what needs to be considered when selecting such a solution to best suit the company’s business and vision.

For more information or to register for this event, visit How to Select and Implement a Product Innovation Platform for PLM in a Life Sciences Company.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

“Corporate initiatives and donations like the one from Atlas help us continue serving our local community and communities across the country through life-saving programs and research.” —Julie Brock, special events and volunteer manager at Susan G. Komen Greater Atlanta

ATLANTA (PRWEB)
October 22, 2019

Atlas Roofing Corporation, along with their dedicated network of contractors throughout the U.S., have raised over $160,000 to support the fight against breast cancer through the Summit 60® Pink initiative. From August 15 through October 15, a portion of the proceeds of every roll of Summit 60 synthetic roof underlayment sold was donated to the Susan G. Komen breast cancer foundation.

As part of the national initiative, Atlas debuted its special-edition Summit 60 Pink premium synthetic roof underlayment embellished with pink ribbons, the international symbol of breast cancer awareness.

“The goal of our Susan G. Komen Pink campaign was to provide much-needed awareness and funding for critical research and education,” explained Kirk Villar, vice president of sales and marketing for Atlas. “We are very proud of the funds we have raised through this partnership, and we will continue to donate our time and efforts to the fight against breast cancer.”

According to the Centers for Disease Control and Prevention, breast cancer is the second most common cause of death for women among all races and ethnicities in the United States.

“The special-edition rolls were a great way for Atlas and our contractors to show our dedication to the fight against breast cancer,” said Tiara Searcy, content and digital marketing manager for Atlas. “Together, we can help make a difference.”

The Susan G. Komen foundation, launched in 1982, has funded more than $988 million in research and more than $2.2 billion in education, screenings and treatment programs across the U.S.

“We are so grateful to receive this donation from Atlas Roofing Corporation,” said Julie Brock, special events and volunteer manager at Susan G. Komen Greater Atlanta. “Corporate initiatives and donations like the one from Atlas help us continue serving our local community and communities across the country through life-saving programs and research.”

Designed To Protect

Summit 60 is designed to optimize the life of a roof system through superior water resistance and UV protection, protecting against water intrusion and mold growth. Made from a woven polymeric scrim, Summit 60 is designed for increased strength, reduced slippage between the underlayment and the roof sheathing and improved walkability during installation. The materials will not warp, buckle or crack over time like other organic felt brands. The UV coating provides 60-day protection from the sun while the roof is being installed.

For more information on Summit 60 underlayment, please visit atlasroofing.com.

About Susan G. Komen

Susan G. Komen® is the world’s leading nonprofit breast cancer organization, working to save lives and end breast cancer forever. Komen has an unmatched, comprehensive 360-degree approach to fighting this disease across all fronts and supporting millions of people in the U.S. and in countries worldwide. We advocate for patients, drive research breakthroughs, improve access to high-quality care, offer direct patient support and empower people with trustworthy information. Founded by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy’s life, Komen remains committed to supporting those affected by breast cancer today, while tirelessly searching for tomorrow’s cures. Visit komen.org or call 1-877 GO KOMEN. Connect with us on social at ww5.komen.org/social.

About Atlas Roofing

Atlas Roofing Corporation is an innovative, customer-oriented manufacturer of residential and commercial building materials. Atlas has grown from a single shingle-manufacturing plant into an industry leader with 31 facilities across North America. Stay connected with us at AtlasRoofing.com or on Facebook, Twitter and YouTube.

Share article on social media or email:

Tracy Callahan and Chris Adigun, MD

As a four time melanoma survivor, I know all too well the importance of early detection; it saves lives, and I am truly fortunate to be able to use my voice and experiences to educate, advocate and promote the early detection of melanoma and skin cancer.

ROLLING MEADOWS, Ill. (PRWEB)
October 22, 2019

The American Society for Dermatologic Surgery is pleased to announce Tracy Callahan, founder of The Polka Dot Mama Melanoma Foundation, as the inaugural recipient of its Sun Safe Hero Award, which launched during the Society’s May 2019 Skin Cancer Awareness Month campaign, to recognize consumers who advocate for skin cancer awareness in their communities. Callahan used her multiple melanoma diagnoses to form the Foundation’s mission of awareness, prevention and early detection.

“This is a tremendous honor, and I am truly humbled for the recognition,” said Callahan. “As a four time melanoma survivor, I know all too well the importance of early detection; it saves lives, and I am truly fortunate to be able to use my voice and experiences to educate, advocate and promote the early detection of melanoma and skin cancer. I am grateful to work alongside an incredibly dedicated team of volunteer dermatologists and nurses who help make our efforts possible.”

Inspired by the nickname “Polka Dot Mama,” given to her by her two sons, Tracy started a blog and began to network with survivors and skin cancer organizations across the country. The Polka Dot Mama Melanoma Foundation was granted 501(c)(3) nonprofit status in 2015 and now funds research, hosts skin cancer screenings, raises awareness and educates the community about melanoma.

“Tracy exudes warmth, kindness and genuine sensitivity while directing a purposeful, well-organized nonprofit,” said Chis Adigun, MD, who nominated Callahan for the award. “Tracy pounds the pavement driving support from our dermatology community to provide free skin cancer screenings in our practices and neighboring venues. Tracy possesses a talent for recruiting support that reaches beyond a single charity event or monetary donation; she inspires authentic involvement for the cause.”

“Tracy’s dedication and efforts in spreading the sun safety message is outstanding, and ASDS applauds her efforts through The Polka Dot Mama Melanoma Foundation,” said Ramona Behshad, MD, Chair of the ASDS Public Service Work Group.

About American Society for Dermatologic Surgery

The American Society for Dermatologic Surgery (ASDS) is the largest specialty organization exclusively representing dermatologic surgeons who have unique training and experience to treat the health, function and beauty of skin throughout every stage of life. ASDS members are recognized as leaders in the field of cosmetic and medically necessary skin surgery. They also are pioneers in the field; many are involved in the clinical studies that bring popular treatments to revitalize skin and fill and diminish wrinkles to the forefront. Their work has helped create and enhance many of the devices that remove blemishes, hair and fat, and tighten skin. Dermatologic surgeons also are experts in skin cancer prevention, detection and treatment. As the incidence of skin cancer rises, dermatologic surgeons are committed to taking steps to minimize the life-threatening effects of this disease. For more information, visit asds.net.

Follow ASDS Skin MD on Facebook, Twitter and Instagram.

Locate a dermatologic surgeon in your area: asds.net/find

Share article on social media or email:

Dr. Dan Holtzclaw Named One of the American Academy of Periodontology’s Recommended Speakers

Board-certified by the American Academy of Periodontology, Dr. Holtzclaw is held in high renown by the AAP for his years of experience as a dental implant specialist and thought leader on implantology and reconstructive oral surgery.

AUSTIN, Texas (PRWEB)
October 22, 2019

Dr. Dan Holtzclaw, founder of DIA Dental Implant Center in Austin, TX, has been named as one of the American Academy of Periodontology’s (AAP) list of recommended speakers. This prestigious list is intended to connect continuing education program planners with experts on periodontal health assessment, disease diagnosis, and treatment. Dr. Holtzclaw is one of only 12 doctors to receive recognition from the AAP as an expert oral reconstructive surgery speaker due to his expertise on the most advanced tooth replacement solutions, dental implants.

The AAP is committed to offering continuing education in numerous forms and encourages the unrestricted spreading of knowledge among professionals, not only to expand treatment options, but to improve public health and safety. Each year, the AAP updates the list of recommended speakers to include only the most qualified members who have expertise and presentation experience in specific topic areas. In order to be added to the list, members should have experience presenting to general practice and dental hygiene audiences and have a familiarity with the Academy’s vision for the specialty.

Board-certified by the American Academy of Periodontology, Dr. Holtzclaw is held in high renown by the AAP for his years of experience as a dental implant specialist and thought leader on implantology and reconstructive oral surgery. He has been a keynote speaker at over 150 lectures worldwide and has been published more than 60 times in peer-reviewed journals. Plus, he founded DIA Dental Implant Center, one of the leading dental implant practices in the country.

Dr. Holtzclaw founded DIA Dental Implant Center with the goal to provide world-class dental implant treatment in one convenient location, making it easier on patients seeking a permanent tooth replacement solution. DIA Dental Implant Center not only offers dental implant placement to replace missing teeth, but it provides cutting-edge treatments that are rare to find at other practice throughout the country, such as zygomatic and pterygoid dental implants. DIA Dental Implant Center uses state-of-the-art Zirkonzahn™ technology for each treatment. Plus, patients can receive care from highly experienced oral surgeons, periodontists, and restoration prosthodontists all under one roof.

Those seeking permanent tooth replacement treatment in Austin, TX can connect with any of the esteemed dental implant specialists at DIA Dental Implant Center. To schedule a consultation, visit http://www.diadentalimplants.com or call 512-375-0050.

About the Practice

DIA Dental Implant Center was founded by Dr. Dan Holtzclaw, one of the world’s leading authorities on full arch immediately loaded dental implant treatment. Using experience from thousands of dental implant procedures, Dr. Holtzclaw pioneered the DIArch™ implant teeth-in-a-day treatment concept, which allows patients to receive a new dental implant smile in just one day. With in-house laboratories utilizing world-class Zirkonzahn™ technology, staff oral surgeons, staff prosthodontists, and experienced dental technicians, DIA Dental Implant Center is able to provide industry leading dental implant treatment in one convenient location, eliminating the need for patients to travel to multiple offices, as is required with most traditional dental offices. To learn more about the DIA Dental Implant Center advantage visit http://www.diadentalimplants.com or call 512-375-0050.

Share article on social media or email:

“This was DermBiont’s first clinical trial, and it is rewarding to have met our goals for the study and enabled additional clinical trials. Although primarily designed as a safety study, our team is excited to see signs of a therapeutic response from a single dose of our product.” -Karl Beutner, CEO

BOSTON (PRWEB)
October 22, 2019

DermBiont, a clinical stage microbiome biotechnology company developing topical live biotherapeutics, has announced that its lead program, DBI-001, met its primary safety endpoints, with no application site reactions and no adverse events, in a 12 person open labeled phase 2a clinical trial for the treatment of interdigital tinea pedis (athlete’s foot). Additionally, the trial demonstrated a clinical response with improvement in the signs and symptoms of tinea pedis and demonstrated a reduction in the abundance of Trichophyton rubrum.

Based on the results of the completed phase 2a trial, the company has started enrolling patients in a phase 2b clinical trial, which is a double-blind placebo-controlled study for the treatment of interdigital tenia pedis. The company will also be initiating a clinical trial in onychomycosis in early 2020.

In addition to addressing tinea pedis, DermBiont’s lead candidate, DBI-001, is being evaluated for additional indications related to bacterial infection of the skin. In-vitro, DBI-001 has activity against fungi as well as bacteria. “This was DermBiont’s first clinical trial, and it is rewarding to have met our goals for the study and enabled additional clinical trials. Although primarily designed as a safety study, our team is excited to see signs of a therapeutic response from a single dose of our product,” said Dr. Karl Beutner, CEO of DermBiont.

“We continue to be pleased with the progress of our lead program along with other ongoing discovery and clinical efforts,” added Dr. Robert Brucker, the company’s CSO.

Approximately 15-25% of individuals globally are afflicted with athlete’s foot and about 70% of the global population will suffer from athlete’s foot at least once. There is an unmet clinical need for a therapeutic treatment that addresses the root cause of athlete’s foot, a dysbiosis of the microbiome, and cures this otherwise chronic and recurrent condition. With the success of its ongoing program, DermBiont plans to commercialize the first FDA approved topical live biotherapeutic to treat skin disease.

About DermBiont

DermBiont is a dermatology company leveraging skin microbiome therapeutics to treat the root cause of skin diseases. In addition to advancing DBI-001, the company has a discovery platform based on a library of thousands of microbes isolated from human skin and one of the world’s largest data sets of Nextgen sequencing of the human microbiome across healthy and diseased skin.

Send all inquiries to: press@dermbiont.com

http://www.dermbiont.com

Share article on social media or email:

iMachine™ AI Software from OnviSource offers Multi-Engine AI Technologies

With our new iMachine, powering our proven solutions with multi-engine artificial intelligence, we are well-positioned to assist enterprises in their digital transformation and next generation transition.

DALLAS (PRWEB)
October 22, 2019

OnviSource announced today it has started the deployment of its AI-driven solutions powered by its new proprietary Artificial Intelligence software, called iMachine™. iMachine is the AI technology for Company’s multichannel and advanced analytics, robotic process automation (RPA) and intelligent virtual agent (IVA) or smart bot.

iMachine utilizes advanced AI technologies and artificial neural network (ANN) and offers 3 artificial intelligence engines including NLP/NLU, Machine Learning (ML) and Deep Learning (DL). Company’s solutions are able to utilize the most optimized AI engine pertinent to their specific application. For example, Company’s Intelligent Virtual Agent or smart bot, called Liaa™, primarily utilizes iMachine’s NLP/NLU engine; while Intellecta™ multichannel analytics and Automata™ RPA products may use iMachine’s ML and DL engines for a variety of their AI-driven features.

Use of iMachine by Company’s solutions in analytics, RPA and IVA significantly enhances their capabilities in effectively addressing today’s enterprise and contact center challenges in workforce optimization, customer experience management and business process automation; as well as automating the management of enterprise contents. iMachine can power virtual agents to sound and act similar to live agents while offering faster, more accurate, and consistent customer service. Content of calls, audio files, email, chat, text, and structured or unstructured documents can be analyzed by iMachine for discovering intent, purpose, compliance, categories, sentiment, root causes and complex information otherwise undetected by analytics that do not use AI engines. Using iMachine RPA can automate more complex, repetitive tasks that require deep analysis of unstructured content and events pertinent to complex business processes.

“For over 14 years, OnviSource has provided enterprises and contact centers with a broad range of solutions in optimization and automation,” said Ray Naeini, CEO and Chairman at OnviSource. “AI is finally here to transition enterprises to their next generation of optimization and automation. With our new iMachine, powering our proven solutions with multi-engine artificial intelligence, we are well-positioned to assist enterprises in their digital transformation and next generation transition.”

iMachine is equipped with user interfaces and training modules supporting its multiple engines. Users can select the most optimal engine(s) for their applications and train iMachine for their specific use cases. OnviSource also offers a series of professional services to assist customers in training iMachine for various applications. iMachine engines are also accessible through OnviSource’s open API platform for integration with third-party applications.

Historically, the use of AI technologies and AI-driven intelligent automation solutions (such as RPA and IVA) by enterprises required significant investment and qualified resources, hence, they were not affordable by all enterprises. Successful deployment of AI-powered solutions and full recognition of its Return-on-Investment (ROI) requires offering special programs beyond the technologies and products. OnviSource’s mission is to democratize AI and intelligent automation solutions for enterprises of all sizes by offering highly affordable prices, delivery options of on-premise software or SaaS, flexibility in customization, free consultation and proof-of-concepts; as well as post-sale operational assistance, at no charge, to assure its solutions work for customers’ specific needs.

About OnviSource

For more than a decade, OnviSource has enabled several hundred small-to-large companies across a broad range of industries to cost-effectively manage, automate and improve their customer experience and business processes by offering advanced solutions in multichannel data and media capture, unification, analysis, decision making and automation for their entire enterprise, including their contact centers, back offices and IT organizations.

OnviSource ia.Enterprise intelligently automated (IA) solutions offer workforce optimization and workforce management (WFO/WFM), all-inclusive Teleservice Customer Engagement Management, Multichannel Customer Engagement Analytics, intelligently automated Customer Survey, process automation through Robotic Process Automation (RPA) and Intelligent Process Automation (IPA), and Intelligent Virtual Agent (IVA).

The Company delivers its solutions as software products, cloud or Software-as-a-Service (SaaS), managed services, or any combination. OnviSource’s special Advantage Plus Program assures the solutions work for customers’ specific needs by offering a series of customer assistance programs with no obligations, including consultation, proof-of-concept, and hands-on operation assistance. OnviSource is headquartered in Plano, Texas (North Dallas area), with an additional operation center in Oklahoma.

Media Contact

Deborah Cromwell, Marketing Manager

OnviSource, Inc.

580.249.9405

deborah.cromwell@onvisource.com

Share article on social media or email:

Drs. Jessica and Thomas Gibbs, Dentists in Glen Ellyn, IL, Offer Flexible Financing Options

When treatments such as orthodontic care or dental implant placement exceed a patient’s budget, third-party financing options can be the bridge between bad teeth and a healthy, attractive smile.

Glen Ellyn, IL (PRWEB)
October 22, 2019

Dentists in Glen Ellyn, IL, Drs. Thomas and Jessica Gibbs, offer affordable dental care, including orthodontics, cosmetic treatment, and dental implants with LendingClub flexible financing. LendingClub helps patients budget their care by distributing the cost of treatment into personalized low monthly payments.

A beautiful smile is made up of teeth that function properly and look attractive. Along with improving health, a beautiful smile improves the patient’s confidence in his or herself. When treatments such as orthodontic care or dental implant placement exceed a patient’s budget, third-party financing options can be the bridge between bad teeth and a healthy, attractive smile. Drs. Gibbs offer LendingClub flexible financing to ensure their patients are getting the dental care they need.

LendingClub is a third-party financing company that offers low monthly payment plans to help patients afford cosmetic, orthodontic, or restorative dental care. Patients can pre-qualify and discover their payment options without a credit check. Plus, they can personalize their monthly payments to fit their personal budgets. With low, fixed rates, LendingClub can help patients of Drs. Gibbs at Smile Glen Ellyn receive the services they need to achieve a healthy, functional, and beautiful smile.

Smile Glen Ellyn offers comprehensive dental services, including single and full arch dental implants, Invisalign® orthodontics, cosmetics, and preventive care. Drs. Gibbs have over 30 years of combined experience in dentistry and remain dedicated to improving the smiles and lives of their patients. They combine advanced technology, state-of-the-art treatment, and multiple sedation options to give patients a comfortable experience and effective, long-lasting results. Using LendingClub financing, they are pleased to be able to provide dental services to a greater number of patients in the Glen Ellyn, IL community.

Patients looking for a dentist in Glen Ellyn, IL offering third-party financing for dental implants and other treatments can schedule their appointment at Smile Glen Ellyn today. Drs. Gibbs can be contacted by calling 630-858-8800 or visiting http://www.smileglenellyn.com.

About the Practice

Smile Glen Ellyn has been offering the community of Glen Ellyn, IL, comprehensive dental care for over 30 years. Drs. Thomas and Jessica Gibbs provide leading-edge care in their family-friendly office, providing a range of services from general and preventative care, to restorative and cosmetic dentistry. The team specializes in gentle dentistry through sedation options, including offering advanced IV sedation for those with extreme dental anxiety. The practice is proud to improve the oral health and aesthetics of patients’ smiles in a comforting atmosphere. To learn more about Drs. Thomas and Jessica Gibbs, their team or the services they offer, visit http://www.smileglenellyn.com or call 630-858-8800 to schedule a one-on-one consultation.

Share article on social media or email: